Art Polk is a fractional CFO/CBO and corporate development leader specializing in the intersection of finance, strategy, and science within the AI-era life sciences sector. An MBA from The Wharton School, he has co-founded multiple biotech startups, including Tinker Therapeutics and PetDx, focusing on therapeutics and advanced diagnostics.
He has a significant background in developing platforms for both human and animal health. His work has spanned novel therapeutics, multi-cancer early detection through liquid biopsy, and large-scale clinical genomics aimed at improving health equity for underrepresented populations.
Unique fact: Art co-authored a clinical study on a next-generation sequencing blood test for early cancer detection in over 1, 000 dogs and holds a related patent.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.